Cambridge Trust’s AbbVie ABBV Stock Holding History

Cambridge Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$4.6M	Sell	25,253 -2,566	-9%	-$442K	0.17%	96
2023 Q4	$4.31M	Buy	27,819 +119	+0.4%	+$17.3K	0.18%	94
2023 Q3	$4.13M	Sell	27,700 -2,508	-8%	-$368K	0.19%	91
2023 Q2	$4.07M	Sell	30,208 -3,446	-10%	-$505K	0.18%	89
2023 Q1	$5.36M	Sell	33,654 -2,118	-6%	-$324K	0.26%	79
2022 Q4	$5.78M	Buy	35,772 +1,659	+5%	+$254K	0.26%	79
2022 Q3	$4.58M	Sell	34,113 -1,132	-3%	-$162K	0.22%	88
2022 Q2	$5.4M	Sell	35,245 -1,598	-4%	-$244K	0.24%	87
2022 Q1	$5.97M	Sell	36,843 -2,138	-5%	-$311K	0.21%	93
2021 Q4	$5.28M	Buy	38,981 +2,829	+8%	+$334K	0.17%	98
2021 Q3	$3.9M	Sell	36,152 -75	-0.2%	-$8.57K	0.15%	95
2021 Q2	$4.08M	Sell	36,227 -1,222	-3%	-$138K	0.15%	96
2021 Q1	$4.05M	Buy	37,449 +3,665	+11%	+$392K	0.17%	95
2020 Q4	$3.62M	Sell	33,784 -2,488	-7%	-$239K	0.17%	83
2020 Q3	$3.18M	Sell	36,272 -2,494	-6%	-$235K	0.16%	84
2020 Q2	$3.65M	Sell	38,766 -707	-2%	-$62.2K	0.19%	80
2020 Q1	$3.01M	Buy	39,473 +742	+2%	+$63.2K	0.21%	79
2019 Q4	$3.43M	Buy	38,731 +2,282	+6%	+$189K	0.18%	92
2019 Q3	$2.76M	Sell	36,449 -2,149	-6%	-$147K	0.16%	88
2019 Q2	$2.81M	Sell	38,598 -577	-1%	-$45.4K	0.16%	88
2019 Q1	$3.16M	Sell	39,175 -1,081	-3%	-$88.4K	0.19%	85
2018 Q4	$3.71M	Sell	40,256 -9,938	-20%	-$874K	0.26%	79
2018 Q3	$4.75M	Sell	50,194 -1,166	-2%	-$111K	0.27%	79
2018 Q2	$4.76M	Sell	51,360 -1,563	-3%	-$153K	0.3%	80
2018 Q1	$5.01M	Sell	52,923 -2,805	-5%	-$308K	0.32%	80
2017 Q4	$5.39M	Sell	55,728 -8,591	-13%	-$810K	0.34%	74
2017 Q3	$5.72M	Sell	64,319 -681	-1%	-$51.8K	0.38%	71
2017 Q2	$4.71M	Sell	65,000 -7,977	-11%	-$536K	0.33%	77
2017 Q1	$4.75M	Sell	72,977 -1,868	-2%	-$117K	0.32%	81
2016 Q4	$4.69M	Buy	74,845 +402	+0.5%	+$24.5K	0.33%	77
2016 Q3	$4.7M	Sell	74,443 -1,458	-2%	-$94.4K	0.34%	77
2016 Q2	$4.7M	Sell	75,901 -7,271	-9%	-$443K	0.36%	75
2016 Q1	$4.75M	Buy	83,172 +11,635	+16%	+$648K	0.39%	69
2015 Q4	$4.24M	Sell	71,537 -1,477	-2%	-$85.1K	0.35%	73
2015 Q3	$3.97M	Buy	73,014 +22,134	+44%	+$1.44M	0.35%	70
2015 Q2	$3.42M	Sell	50,880 -3,941	-7%	-$257K	0.28%	79
2015 Q1	$3.21M	Sell	54,821 -4,782	-8%	-$289K	0.27%	83
2014 Q4	$3.9M	Buy	59,603 +3,078	+5%	+$194K	0.34%	69
2014 Q3	$3.27M	Buy	56,525 +2,694	+5%	+$150K	0.29%	71
2014 Q2	$3.04M	Sell	53,831 -1,539	-3%	-$80.7K	0.26%	72
2014 Q1	$2.85M	Sell	55,370 -884	-2%	-$44.7K	0.26%	75
2013 Q4	$2.97M	Sell	56,254 -75	-0.1%	-$3.69K	0.28%	72
2013 Q3	$2.52M	Sell	56,329 -1,629	-3%	-$72.2K	0.25%	75
2013 Q2	$2.4M	Buy	+57,958	New	+$2.53M	0.25%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cambridge Trust's ABBV Position: Q1 2024 in Review

Cambridge Trust reduced its AbbVie (ABBV) stake by 9.2% in Q1 2024, selling an estimated $442K and leaving 25,253 shares worth $4.6M. The position accounts for 0.17% of the portfolio, ranked #96.

Cambridge Trust first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. The position peaked at $5.97M in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Cambridge Trust held 25,253 shares of AbbVie worth $4.6M as of Q1 2024.
Cambridge Trust sold 2,566 AbbVie shares in Q1 2024, an estimated $442K.
AbbVie made up 0.17% of Cambridge Trust's portfolio in Q1 2024, its #96 holding.
Cambridge Trust first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
Cambridge Trust's AbbVie position peaked at $5.97M in Q1 2022.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.